Aarnisalo P, Palvimo JJ, Jänne OA (1998) CREB-binding protein in androgen receptor-mediated signaling. Proc Nal Acad Sci USA 95:2122-2127 Abel A, Walcott J, Woods JA, Duda J, Merry, DE (2001) Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. Hum Mol Genet 2:107-116 Abdullah AAR, Trifiro MA, Panet-Raymond V, Alvarado, C, de Tourreil S, Frankel D, Schipper HM, Pinsky L (1998) Spinobulbar muscular atrophy: polyglutamine-expanded androgen receptor is proteolytically resistant in vitro and processed abnormally in transfected cells. Hum Mol Genet 7:379-384

Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, Do J, Sang C, Kobayashi Y, Doyu M, Sobue G (2001) Transgenic mice with an expanded CAG repeat controlled by human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death. Hum Mol Genet 10:1039-1048 Adler AJ, Scheller A, Robins DM (1993) The stringency and magnitude of androgen-specific gene activation are combinatorial functions of receptor and nonreceptor binding site sequences. Mol Cell Biol 13:6326-6335

Alen P, Claessens F, Verhoeven G, Rombauts W, Peeters B (1999) The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol Cell Biol 19:6085-6097

Afrin LB, Ergul SM (2000) Medical therapy of prostate cancer: 1999. J S C Med Assoc 96:77-84

Amero SA, Kretsinger RH, Moncrief ND, Yamamoto KR, Pearson WR (1992) The origin of nuclear receptor proteins: a single precursor distinct from other transcription factors. Mol Endocrinol 6:3-7

Anzick SL, Kononen J, Walker RL, Azorsa DO. Tanner MM, Guan XY. Sauter G, Kallioniemi OP, Trent JM, Meltzer PS (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968 Arbizu T, Santamaria J, Gomez JM, Quilez A, Serra JP (1983) A family with adult onset spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure. J Neurol Sci 59:371-382.

Auclerc G, Antoine EC, Cajfinger F, Brunet-Pommeyrol A, Agazia C, Khayat D (2000) Management of advanced prostate cancer. Oncologist 5:36-44 Baarends WM, Themmen AP, Blok LJ, Mackenbach P, Brinkmann AO, Meijer D, Faber PW, Trap-man J, Grootegoed JA (1990) The rat androgen receptor gene promoter. Mol Cell Endocrinol 74:75-84

Bailey CK, Andriola IFM, Kampinga HH, Merry DE (2002) Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Hum Mol Genet 5:515-523 Bartsch G, Rittmaster RS, Klocker H (2000) Dihydrotestosterone and the concept of 5alpha-

reductase inhibition in human benign prostatic hyperplasia. Eur Urol 37:367-380 Becker M, Martin E, Schneikert J, Krug HF, Cato ACB (2000) Cytoplasmic localisation and the choice of ligand determine aggregate formation by androgen receptor with amplified polyglutamine stretch. J Cell Biol 149:255-262 Beilin J, Ball EM, Favaloro JM, Zajac JD (2000) Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol 25:85-96 Belsham DD, Yee WC, Greenberg CR, Wrogemann K (1992) Analysis of the CAG repeat region of the androgen receptor gene in a kindred with X-linked spinal and bulbar muscular atrophy. J Neurol Sci 112:133-138 Benten WPM, Lieberherr M, Sekeris CE, Wunderlich F (1997) Testosterone induuces Ca2+ influx via non-genomic surface receptors in activated T cells. FEBS Lett 407:211-214 Benten WPM, Lieberherr M, Stamm O, Wrehlke C, Guo Z, Wunderlich F (1999) Testosterone signaling through internalizable surface receptors in anndrogen receptor-free macrophages. Mol Biol Cell 10:3113-3123 Berrevoets CA, Doesburg P, Steketee K, Trapman J, Brinkmann AO (1998) Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor 2). Mol Endocrinol 12:1172-1183 Bevan CL, Hoare S, Claessens F, Heery DM, Parker MG (1999) The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol 19:83838392

Bimston D, Song J, Winchester D, Takayama S, Reed JC, Morimoto RI (1998) BAG-1, a negative regulator of Hsp70 chaperone activity, uncouples nucleotide hydrolysis from substrate release. EMBO J 17:6871-6878.

Bingham PM, Scott MO, Wang S, McPhaul MJ, Wilson EM, Garbern JY, Merry DE, Fischbeck KH (1995) Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice. Nat Genet 9:191-196 Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Mailer JL, Miller WT, Edwards DP (2001) Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family of tyrosine kinases. Mol Cell 8:269-280 Brady ME, Ozanne DM, Gaughan L, Waite I, Cook S, Neal DE, Robson, CN (1999) Tip60 is a nuclear hormone receptor coactivator. J Biol Chem 274:17599-17604 Brooks BP, Fischbeck KH (1995) Spinal and bulbar muscular atrophy: a trinucleotide-repeat expansion neurodegenerative disease. Trends Neurosci 18:459-461 Brown CJ, Goss SJ, Lubahn DB, Joseph DR, Wilson EM, French FS, Willard HF (1989) Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet 44: 264-269 Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch MJ, Sauter G, Kallioniemi OP (1999) Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res 59:803806

Bubley G, Fenton M, Fertig A (1996). The hormonal sensitivity of androgen receptor (AR)

mutations derived from human tumors (Abstract) Cancer Res 37:1680A Bubulya A, Chen SY, Fisher CJ, Zheng Z, Shen XQ, Shemshedini L (2001) c-Jun potentiates the functional interaction between the amino and carboxyl termini of the androgen receptor. J Biol Chem 276:44704-44711 Buchanan G, Greenberg NM, Scher HI, Harris JM, Marshall VR, Tilley WD (2001) Collocation of androgen receptor gene mutations in prostate cancer. Clin Cancer Res 7:1273-1281 Buchanan G, Yang M, Harris JM, Nahm HS, Han G, Moore N, Bentel JM, Matusik RJ, Horsfall DJ, Marshall VR et al. (2001) Mutations at the boundary of the hinge and ligand binding domain ofthe androgen receptor confer increasedtransactivation function. Mol Endocrinol 15: 46-56

Burfeind P, Chernicky CL, Rininsland F, Ilan J (1996) Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc Natl Acad Sci USA 93:7263-7268 Burgess LH, Handa RJ (1993) Hormonal regulation of androgen receptor mRNA in the brain and anterior pituitary gland of the male rat. Brain Res Mol Brain Res 19:31-38 Butler R, Leigh PN, McPhaul MJ, Gallo J-M (1998) Truncated forms ofthe androgen receptor are associated with polyglutamine expansion in X-linked spinal and bulbar atrophy. Hum Mol Genet 7:121-127

Buttyan R, Ghafar MA, Shabsigh A (2000) The effects of androgen deprivation on the prostate gland: cell death mediated by vascular regression. Curr Opin Urol 10:415-420 Caldiroli M, Cova V, Lovisolo JA, Reali L, Bono, AV (2001) Antiandrogen withdrawal in the treatment of hormone-relapsed prostate cancer: single institutional experience. Eur Urol 39 Suppl S2:6-10

Caplan AJ, Langley E, Wilson EM, Vidal J (1995) Hormone-dependent transactivation by the human androgen receptor is regulated by a dnaJ protein. J Biol Chem 270:5251-5257

Castoria G, Lombardi M, Barone MV, Bilancio A, Di Domanico M, Bottero D, Vitale F, Migli-accio A, Auricchio F (2003) Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J Cell Biol 161:547-556 Cato ACB, Peterziel H (1998) The androgen receptor as mediator of gene expression and signal transduction pathways. Trends Endocrinol Metab 9:150-154 Cato ACB, Nestl A, Mink S (2002) Rapid actions of steroid receptors in cellular signaling pathways. Science's STKE 138 re9

Chamberlain NL, Driver, ED, Miesfeld, RL (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181-3186 Chamberlain NL, Whitacre DC, Miesfeld RL (1996) Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. J Biol Chem 271:26772-26778 Chan HYE, Warrick JW, Andriola I, Merry D, Bonini NM (2002) Genetic modulation of polyglu-tamine toxicity by protein conjugation pathways in Drosophila. Hum Mol Gen 11:2895-2904 Chang CS, Kokontis J, Liao ST (1988a) Molecular cloning of human and rat complementary

DNA encoding androgen receptors. Science 240:324-326 Chang CS, Kokontis J, Liao ST (1988b) Structural analysis of complementary DNA and amino acid sequences ofhuman and rat androgen receptors. Proc Natl Acad Sci USA 85:7211-7215 Chang C, Saltzman A, Yeh S, Young W, Keller E, Lee HJ, Wang C, Mizokami A (1995) Androgen receptor: an overview. Crit Rev Eukaryot Gene Expr 5:97-125 Chang BL, Zheng SL, Hawkins GA, Isaacs SD, Wiley KE, Turner A, Carpten JD, Bleecker ER, Walsh PC, Trent JM, et al. (2002) Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk. Hum Genet 110:122-129 Chen S, Smith DF (1998) Hop as an adaptor in the heat shock protein 70 (Hsp70) and hsp90

chaperone machinery. J Biol Chem 273:35194-35200 Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y Evans RM (1997) Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580 Chen RS, Huang CC, Chu NS, Cheng CC, Wei YH (1999) Random X chromosome methylation patterns in the carriers with clinical phenotypic expressions of X-linked recessive bulbospinal neuronopathy. Acta Neurol Scand 1004:249-53 Chen T, Wang LH, Farrar, WL (2000) Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Cancer Res. 60:2132-2135 Chen C, Lamharzi N, Weiss NS, Etzioni R, Dightman DA, Barnett M, DiTommaso D, Goodman G (2002) Androgen receptor polymorphisms and the incidence of prostate cancer. Cancer Epidemiol Biomarkers Prev 11:1033-1040 ChesireDR, Isaacs WB (2002) Ligand-dependent inhibition of b-catenin/TCF signaling by androgen receptor. Oncogene 21:8453-8469 Chipuk JE, Cornelius SC, Pultz NJ, Jorgensen JS, Bonham MJ, Kim S-J, Danielpour D (2002) The androgen receptor represses transforming growth-b signaling through interaction with Smad3. J Biol Chem 277:1240-1248 Choong CS, Wilson EM (1998) Trinucleotide repeats in the human androgen receptor: a molecular basis for disease. J Mol Endocrinol 21:235-257

Ciardello F, Tortora G (1998) Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications. Clin Cancer Res 4:821-828

Claessens F, Dirckx L, Delaey B, Decourt JL, Hemschoote K, Peeters B, Rombauts W (1989) The androgen-dependent rat prostatic binding protein: comparison of the sequences in the 5' part and upstream region oftheC1 and C2 genes and analysis oftheir transcripts. J Mol Endocrinol 3:93-103.

Claessens F, Celis L, De Vos P, Heyns W, Verhoeven G, Peeters B, Rombauts W (1993) Functional androgen response elements in the genes coding for prostatic binding protein. Ann N Y Acad Sci 684:199-201

Claessens F, Alen P, Devos A, Peeters B, Verhoeven G, Rombauts W (1996) The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors. J Biol Chem 271:19013-19016 Coffey DS, Isaacs JT (1981) Control of prostate growth. Urology 17:17-24 Cook GB, Watson FR (1968) A comparison by age of death rates due to prostate cancer alone. J Urol 100:669-671

Cowan KJ, Diamond MI, Welch WJ (2003) Polyglutamine protein aggregation and toxicity are linked to the cellular stress response. Hum Mol Genet 12:1377-1391 Craft N, Chhor C, Tran C, Belldegrun A, DeKernion J, Witte QN, Said J, Reiter RE, Sawyers CL (1999a) Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-independent tumors through a two-step process. Cancer Res 59:50305036

Craft N, Shostak Y, Carey M, Sawyers CL (1999b) A mechanism for hormone-independent prostate cancer through modification of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Medicine 5:280-285 Cram DS, Song B, McLachlan RI, Trounson AO (2000) CAG trinucleotide repeats in the androgen receptor gene of infertile men exhibit stable inheritance in female offspring conceived after ICSI. Mol Hum Reprod 6:861-866 Crawford ED, Rosenblum M, Ziada AM, Lange PH (1999) Hormone refractory prostate cancer. Urology 54:1-7

Culig Z, Hobisch A, Cronauer MV, Cato AC, Hittmair A, Radmayr C, Eberle J, Bartsch G, Klocker H (1993) Mutant androgen receptor detected in an advanced stage of prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol 7:1541-1550 Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H (1994) Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54:54745478

Culig Z, Hobisch A, Hittmair A, Cronauer MV, Radmayr C, Zhang J, Bartsch G, Klocker H (1997) Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells. Prostate 32:106-114 Culig Z, Hoffmann J, Er del M, Eder IE, Hobisch A, Hittmair A, Bartsch G, Utermann G, Schneider MR, Parczyk K, Klocker H (1999) Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br J Cancer 81:242-251

Culig Z, Hobisch A, Bartsch G, Klocker H (2000) Expression and function of androgen receptor in carcinoma of the prostate. Microsc Res Tech 51:447-455 Culig Z, Klocker H, Bartsch G, Hobisch A (2001) Androgen receptor mutations in carcinoma of the prostate: significance for endocrine therapy. Am J Pharmacogenomics 1:241-249 Culig Z, Klocker H, Bartsch G, Hobisch A (2002) Androgen receptors in prostate cancer. Endocr Relat Cancer 9:155-170

Culig Z, Hobisch A, Erdel M, Bartsch G, Klocker H (2003) Studies on androgen receptor mutations and amplification in human prostate cancer. Methods Mol Med 81:267-275 Cunha GR (1984) Androgenic effects upon prostatic epithelium via tropic influences from stroma.

Prog Clin Biol Res 145:81-102 Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, Foster BA (1992) Normal and abnormal development of the male urogenital tract - role of androgens, mesenchymal-epithelial interactions, and growth factors. J Androl 13:465-475 Darne C, Veyssiere G, Jean C (1998) Phorbol ester causes ligand-independent activation of the androgen receptor. Eur J Biochem 256:541-549 Darrington RS, Butler R, Leigh PN, McPhaul MJ, Gallo J-M (2002) Ligand-dependent aggregation ofpolyglutamine-expanded androgen receptor in neuronal cells. NeuroReport 13:2117-2120 De Winter JA, Trapman J, Brinkmann AO, Boersma WJA, Mulder E, Schroeder FH, Claassen E, van der Kwast TH (1990) Androgen receptor heterogenity in human prostatic carcinomas visualized by immunohistochemistry. J Pathol 160:329-332 Dedhar S, Rennie PS, Shago M, Hagesteijn C-YL, Yang H, Filmus J, Hawley RG, Bruchovsky N, Cheng H, Matusik RJ, Giguere V (1994) Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367:480-483 Denmeade SR, Lin XS, Isaacs JT (1996) Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate 28:251-265 Diamond DA, Barrack ER (1984) The relationship of androgen receptor levels to androgen responsiveness in the Dunning R3327 rat prostate tumor sublines. J Urol 132:821-827 DiPaola RS, Kumar P, Hait WN, Weiss RE (2001) State-of-the-art prostate cancer treatment and research. A report from the Cancer Institute of New Jersey. N J Med 98:23-33 Dittmar KD, Pratt WB (1997) Folding of the glucocorticoid receptor by the reconstituted Hsp90-based chaperone machinery. The initial hsp90.p60.hsp70-dependent step is sufficient for creating the steroid binding conformation. J Biol Chem 272:13047-13054 Dittmar KD, Banach M, Galigniana MD, Pratt WB (1998) The role of DnaJ-like proteins in glucocorticoid receptor.hsp90 heterocomplex assembly by the reconstituted hsp90.p60.hsp70 foldosome complex. J Biol Chem 273:7358-7366 Eder I, Culig Z, Ramoner R, Thurnher M, Putz T, Nessler-Menardi C, Tiefenthaler M, Bartsch, G, Klocker H (2000) Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides. Cancer Gene Therapy 7:997-1007 Eder IE, Culig Z, Putz T, Nessler-Menardi C, Bartsch G, Klocker H (2001) Molecular biology of the androgen receptor: from molecular understanding to the clinic. Eur Urol 40:241-251 Ellerby LM, Hackam AS, Propp SS, Ellerby HM, Rabizadeh S, Cashman NR, Trifiro MA, Pinsky L, Wellington CL, Salvesen GS, Hayden MR, Bredesen DE (1999) Kennedy's disease: caspase cleavage ofthe androgen receptor is a crucial event in cytotoxicity. J Neurochem 72:185-195

Elo JP, Kvist L, Leinonen K, Isomaa V, Henttu P, Lukkarinen O, Vihko P (1995) Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol. J Clin Endocrinol Metab 80:3494-3500 English HF, Kyprianou N, Isaacs JT (1989) Relationship between DNA fragmentation and apop-tosis in the programmed cell death in the rat prostate following castration. Prostate 15:233-250 Faber, PW, van Rooij HC, van der Korput HA, Baarends WM, Brinkmann AO, Grootegoed JA, Trapman J (1991) Characterization of the human androgen receptor transcription unit. J Biol Chem 266:10743-10749 Faber PW, van Rooij HC, Schipper HJ, Brinkmann AO, Trapman J (1993) Two different, overlapping pathways of transcription initiation are active on the TATA-less human androgen receptor promoter. The role of Sp1. J Biol Chem 268:9296-9301 Fang Y, Fliss AE, Robins DM, Caplan AJ (1996) Hsp90 regulates androgen receptor hormone binding affinity in vivo, J Biol Chem 271:28697-28702 Feldman BJ, Feldman D (2001) The development of androgen-independent prostate cancer.

Nature Rev Cancer 1:34-45 Fliss AE, Fang Y, Boschelli F Caplan AJ (1997) Differential in vivo regulation of steroid hormone receptor activation by Cdc37p. Mol Biol Cell 8:2501-2509 Freedman LP, Luisi BF, Korszun ZR, Basavappa R, Sigler PB, Yamamoto KR (1988) The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature 334:543-546 Froesch, BA, Takayama S, Reed JC (1998) BAG-1L protein enhances androgen receptor action.

J Biol Chem 273:11660-11666 Fronsdal K, Engedal N, Slagsvold T, Saatcioglu F (1998) CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1. J Biol Chem 273: 31853-31859 Fu M, Wang C, Reutens AT, Wang J, Angeletti RH, Siconolfi-Baez L, Ogryzko V, Avantaggiati M-L, Pestell RG (2000) p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem 275:20853-20860 Fuller PJ (1991) The steroid nuclear receptor superfamily: mechanisms of diversity. FASEB J 5:2243-2249

Gaddipati JP, McLeod DG, Heidenberg HB, Sesterhenn IA, Finger MJ, Moul JW, Srivastava S (1994) Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res 54:2861-2864 GaoM, OssowskiL, Ferrari AC (1999) Activation of Rb and decline in androgen receptor precede retinoic acid-induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivative. J Cell Physiol 179:336-346. Gebauer M, Zeiner M, Gehring U (1998) Interference between proteins Hap46 and Hop/p60, which bind to different domains of the molecular chaperone hsp70/hsc70. Mol Cell Biol 18:6238-6244

Geller J (1991) Review of assessment of total androgen blockade as treatment of metastatic prostate cancer. J Endocrinol Invest 14:881-891 Glass CK, Rose DW, Rosenfeld MG (1997) Nuclear receptor coactivators. Curr Opin Cell Biol 9:222-232

Glass CK, Rosenfeld MG (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14:121-141 Gottlieb B, Beitel LK, Trifiro MA (2001) Variable expressivity and mutation databases: The androgen receptor gene mutations database. Hum Mutat 17:382-388 Griffin JE, Wilson JD (1989) The androgen resistance syndromes: 5a-reductase deficiency, testicular feminization, and related syndromes. 6th ed McGraw-Hill New York Grigoryev DN, Long BJ, Njar VC, Brodie AH (2000) Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor. J Steroid Biochem Mol Biol 75:1-10

Grossmann ME, Tindall DJ (1995) The androgen receptor is transcriptionally suppressed by proteins that bind single-stranded DNA. J Biol Chem 270:10968-10975 Grossmann ME, Lindzey J, Blok L, Perry JE, Kumar MV, Tindall DJ (1994a) The mouse androgen receptor gene contains a second functional promoter which is regulated by dihydrotestosterone. Biochemistry 33:14594-14600 Grossmann ME, Lindzey J, Kumar MV, Tindall DJ (1994b) The mouse androgen receptor is suppressed by the 5'-untranslated region of the gene. Mol Endocrinol 8:448-455 Grossmann ME, Huang H, Tindall DJ (2001) Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst 93:1687-1697 Guidetti D, Vescovini E, Motti L, Ghidoni E, Gemignani F, Marbini A, Patrosso MC, Ferlini A, Solime F (1996) X-linked bulbar and spinal muscular atrophy, or Kennedy disease: clinical, neurophysiological, neuropathological, neuropsychological and molecular study of a large family. J Neurol Sci 135:140-148 Hager GL (2000) Understanding nuclear receptor function: from DNA to chromatin to the interphase nucleus. Prog Nucleic Acid Res Mol Biol 66:279-305 Hara T, Miyazaki J, Araki H, Yamaoka M, Kanzaki N, Kusaka M, Miyamoto M (2003) Novel mutations ofandrogen receptor: a possible mechanism ofbicalutamide withdrawal syndrome. Cancer Res 63:149-153

Harada S, Keller ET, Fujimoto N, Koshida K, Namiki M, Matsumoto T, Mizokami A (2001) Long-term exposure of tumor necrosis factor alpha causes hypersensitivity to androgen and anti-androgen withdrawal phenomenon in LNCaP prostate cancer cells. Prostate 46:319-326. He WW, Fischer LM, Sun S, Bilhartz DL, Zhu XP, Young CY, Kelley DB, Tindall DJ (1990) Molecular cloning of androgen receptors from divergent species with a polymerase chain reaction technique: complete cDNA sequence of the mouse androgen receptor and isolation of androgen receptor cDNA probes from dog, guinea pig and clawed frog. Biochem Biophys Res Commun 171:697-704 He B, Kemppainen JA, Voegel JJ, Gronemeyer H, Wilson EM (1999) Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH2-terminal domain. J Biol Chem 274:37219-37225 He B, Kemppainen JA Wilson EM (2000) FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J Biol Chem 275:22986-22994

He B, Lee LW, Minges JT, Wilson EM (2002) Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction. J Biol Chem 277:25631-25639

Heery DM, Kalkhoven E, Hoare S, Parker MG (1997) A signature motif in transcriptional co-

activators mediates binding to nuclear receptors. Nature 387:733-736 Herbst RS (2002) ZD1839: targeting the epidermal growth factor receptor in cancer therapy.

Expert Opin Investig Drugs 11:837-849 Hirai M, Hirata S, Osada T, Hagihara K, Kato J (1994) Androgen receptor mRNA in the rat ovary and uterus. J Steroid Biochem Mol Biol 49:1-7 Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H, Hittmair A (1995a) Androgen receptor status of lymph node metastases from prostatic carcinoma. Prostate 29:129-136 Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H, Hittmair A (1995b) Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res 55:3068-3072 Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, Klocker H, Culig K (1998) Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res 58:4640-4645 Hohfeld J, Jentsch S (1997) GrpE-like regulation of the hsc70 chaperone by the anti-apoptotic protein BAG-1. EMBO J 16:6209-6216 Hohfeld J, Minami Y, Hartl FU (1995) Hip, a novel cochaperone involved in the eukaryotic

Hsc70/Hsp40 reaction cycle. Cell 83:589-598 Holaska JM, Black BE, Love DC, Hanover JA, Leszyk J, Paschal BM (2001) Calreticulin is a receptor for nuclear export. J Cell Biol 152:127-140 Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP

(1983). LNCaP model ofhuman prostatic carcinoma. Cancer Res 43:1809-1818 Hsiao PW, Lin DL, Nakao R, Chang C (1999) The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator. J Biol Chem 29:20229-20234

Huggins C, Hodges CV (1941) Studies on prostatic cancer: the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1:293-297

Huggins C, Stevens R (1940) The effect of castration on benign hypertrophy of the prostate in men. J Urol 43:705-714

Humphreys DT, Carver JA, Easterbrook-Smith SB, Wilson MR (1999) Clusterin has chaperone-

like activity similar to that of small heat shock proteins. J Biol Chem 274:6875-6881 Hyytinen ER, Haapala K, Thompson J, Lappalainen I, Roiha M, Rantala I, Helin HJ, Janne OA, Vihinen M, Palvimo JJ, Koivisto PA (2002) Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer. Lab Invest 82:1591-1598 Ikonen T, Palvimo JJ, Kallio PJ, Reinikainen P, Janne, OA (1994) Stimulation of androgen-regulated transactivation by modulators ofprotein phosphorylation. Endocrinology 135:13591366

Ikonen T, Palvimo JJ, Janne OA (1997) Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear reactivators. J Biol Chem 272:29821-29828 Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, Coetzee GA (2000) Inhibition ofp160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet 9:267-74

Isaacs JT, Wake N, Coffey DS, Sandberg AA (1982) Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system. Cancer Res 42:2353-2371 Ishihara K, Yamagishi NY, Saito Y, Adachi H, Kobayashi Y, Sobue G, Ohtsuka K, Hatayama T (2003) Hsp105a suppresses the aggregation of truncated androgen receptor with expanded CAG repeats and cell toxicity. J Biol Chem 278:25143-25150 Jenster G, Trapman J, Brinkmann AO (1993) Nuclear import of the human androgen receptor. Biochem J 293:761-768

Jenster G, van der Korput JA, Trapman J, Brinkmann AO (1992) Functional domains of the human androgen receptor. J Steroid Biochem Mol Biol 41:671-675 Jenster G, van der Korput JA, Trapman J, Brinkmann AO (1995) Identification oftwo transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem 270:7341-7346

Johnson BD, Schumacher RJ, Ross, ED, Toft DO (1998) Hop modulates Hsp70/Hsp90 interactions in protein folding. J Biol Chem 273:3679-3686. Kang HY, Yeh S, Fujimoto N Chang C (1999) Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J Biol Chem 274:8570-8576

Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, Sang C, Kobayashi Y, Doyu M, Sobue G (2002) Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35:843-854 Katsuno M, Adachi H, Doyu M, Minamiyama M, Sang C, Kobayashi Y, Inukai A, Sobue G (2003) Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 6:768-773 Kennedy WR, Alter M, Sung JH (1968) Progressive proximal spinal and bulbar muscular atrophy oflate onset. Neurology 18:671-680 Kobayashi Y, Kume A, Li M, Doyu M, Hata M, Ohtsuka K, Sobue G (2000) Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J Biol Chem 275:8772-8778

Koh SS, Li H, Lee YH, Widelitz RB, Chuong CM, Stallcup MR (2002) Synergistic coactivator function by coactivator-associated arginine methyltransferase (CARM) 1 and beta-catenin with two different classes of DNA-binding transcriptional activators. J Biol Chem 277:2603126035

Koivisto P, Visakorpi T, Kallioniemi OP (1996) Androgen receptor gene amplification: a novel molecular mechanism for endocrine therapy resistance in human prostate cancer. Scand J Clin Lab Invest Suppl 226:57-63 Kokontis J, Takakura K, Hay N, Liao S (1994) Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res 54:1566-1573

Kokontis JM, Hay N, Liao S (1998) Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Mol Endocrinol 12:941-953

Kosano H, Stensgard B, Charlesworth MC, McMahon N, Toft D (1998) The assembly of progesterone receptor-hsp90 complexes using purified proteins. J Biol Chem 273:32973-32979 Kotaja N, Karvonen U, Jänne OA, Palvimo JJ (2002a) The nuclear interaction domain of GRIP1

is modulated by covalent attachment of SUMO-1. J Biol Chem 277:30283-30288 Kotaja N, Vihinen M, Palvimo JJ Janne OA (2002b) Androgen receptor-interacting protein 3 and other PIAS proteins cooperate with glucocorticoid receptor-interacting protein 1 in steroid receptor-dependent signaling. J Biol Chem 277:17781-17788 Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC (2001) Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730 Kovtun IV, Therneau TM, McMurray CT (2000) Gender of the embryo contributes to CAG instability in transgenic mice containing a Huntington's disease gene. Hum Mol Genet 18:27672775

Kratochwil K (1986) The stroma and the control of cell growth. J Pathol 149:23-24 Krishnan AV, Zhao XY, Swami S, Brive L, Peehl DM, Ely KR, Feldman D (2002) A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer. Endocrinology 143:1889-1900 Kuil CW, Mulder E (1994) Mechanism of antiandrogen action: conformational changes of the receptor. Mol Cell Endocrinol 102:R1-R5 Kumar MV, Jones EA, Grossmann ME, Blexrud MD, Tindall DJ (1994) Identification and characterization of a suppressor element in the 5'-flanking region of the mouse androgen receptor gene. Nucleic Acids Res 22:3693-3698 Kyprianou N, Isaacs JT (1988) Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122:552-562 Kyprianou N, Isaacs JT (1989) Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 3:1515-1522 La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77-79 La Spada AR, Peterson KR, Meadows SA, McClain ME, Jeng G, Chmelar RS, Haugen HA, Chen K, Singer MJ, Moore D, Trask BJ, Fischbeck KH, Clegg CH, McKnight GS (1998) Androgen receptor YAC transgenic mice carrying CAG 45 alleles show trinucleotide repeat instability. Hum Mol Genet 7:959-967 Labrie F (1995) Endocrine therapy of prostate cancer: optimal form and timing. J Clin Endocrinol Metab 80:1066-1071

Labrie F (1998) Combined androgen blockade and treatment of localized prostate cancer: A real hope when approaching the year 2000. Endocr Rel Cancer 5:341-351 LaFevre-Bernt MA, Ellerby LM (2003) Kennedy's disease: phosphorylation of the polyQ-expanded form of androgen receptor regulates its cleavage by caspase-3 and enhances cell death. J Biol Chem 278:34918-34924 Lamb JC, English H, Levandoski PL, Rhodes GR, Johnson RK, Isaacs JT (1992) Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response. Endocrinology 130:685-694

Langley E, Zhou ZX, Wilson EM (1995) Evidence for an anti-parallel orientation of the ligand-

activated human androgen receptor dimer. J Biol Chem 270:29983-29990 Langley E, Kemppainen JA, Wilson EM (1998) Intermolecular NH2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensi-tivity. J Biol Chem 273:92-101 Le Douarin B, Nielsen AL, Garnier JM, Ichinose H, Jeanmougin F, Losson R, Chambon P (1996) A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J 15:6701-6715 Lee Y-F, Shyr C-R, Thin TH, Lin W-J, Chang C (1999) Convergence of two repressors through heterodimer formation of androgen receptor and testicular orphan receptor-4: a unique signaling pathway in the steroid receptor superfamily. Proc Natl Acad Sci USA 96:14724-14729 Lee DK, Duan HO, Chang C (2000) From androgen receptor to the general transcription factor TFIIH. Identification ofcdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator. J Biol Chem 275:9308-9313 Lee L-F, Guan J, Qui Y, Kung, H-J (2001) Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase. Mol Cell Biol 21:8385-8397 Lee SR, Ramos SM, Ko A, Masiello D, Swanson KD, Lu ML, Balk SP (2002) AR and ER interaction with a p21-activatedkinase (PAK6). Mol Endocrinol 16:85-99 Leewansangtong S, Crawford ED (1998) Maximal androgen withdrawal for prostate cancer therapy: Current status and future potential. Endocr Rel Cancer 5:325-339 Leger JG, Montpetit ML, Tenniswood MP (1987) Characterization and cloning of androgen-

repressed mRNAs from rat ventral prostate. Biochem Biophys Res Commun 147:196-203 Li H, Gomes PJ, Chen JD (1997) RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc Natl Acad Sci USA 94:8479-8484 Li M, Nakagomi Y, Kobayashi Y, Merry DE, Tanaka F, Doyu M, Mitsuma T, Hashizume Y, Fischbeck KH, Sobue G (1998) Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy. Am J Pathol 153:695-701 Li P, Lee H, Guo S, Unterman TG, Jenster G, Bai W (2003) AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR. Mol Cell Biol 23:104-118 Lieberherr M, Grosse B (1994) Androgens increase intracellular calcium concenttration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein. J Biol Chem 269:7217-7223 Lindzey J, Grossmann M, Kumar MV, Tindall DJ (1993) Regulation of the 5'-flanking region of the mouse androgen receptor gene by cAMP and androgen. Mol Endocrinol 7:1530-1540 Linja MJ, Savinainen KJ, Saramaki OR, Tammela TL, Vessella RL, Visakorpi T (2001) Amplification and overexpression of androgen receptor gene in hormone- refractory prostate cancer. Cancer Res 61:3550-3555 Loy CJ, Sim KS, Young EL (2003) Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proc Natl Acad Sci USA 100:4562-4567 Lubahn DB, Joseph DR, Sar M, Tan J, Higgs HN, Larson RE, French FS, Wilson EM (1988a) The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 2:1265-127

Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM (1988b) Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240:327-330

Lubahn DB, Brown TR, Simental JA, Higgs HN, Migeon CJ, Wilson EM, French FS (1989) Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity [published erratum appears in Proc Natl Acad Sci USA 1990; 87:4411]. Proc Natl Acad Sci USA 86:9534-9538

LuisiBF,XuWX, OtwinowskiZ, Freedman LP, Yamamoto KR, Singer PB (1991) Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352:497-505 Lumbroso R, Beitel LK, Vasiliou DM, Trifiro MA, Pinsky L (1997) Codon-usage variants in the polymorphic (GGN)n trinucleotide repeat ofthe human androgen receptor gene. Hum Genet 101:43-46

Lund A, Udd B, Juvonen V, Andersen PM, Cederquist K, Davis M, Gellera C, Kolmel C, Ronnevi LO, Sperfeld AD, Sorensen SA, Tranebjaerg L, Van Maldergem L, Watanabe M, Weber M, Yeung L, Savontaus ML (2001) Multiple founder effects in spinal and bulbar muscular atrophy SBMA, Kennedy disease around the world. Eur J Hum Genet 96:431-436 Lutz LB, Cole LM, Gupta MK, Kwist KW, Auchus RJ, Hammes SR (2001) Evidence that androgens are the primary steroids produced by Xenopus laevis ovaries and may signal through the classical androgen receptor to promote oocyte maturation. Proc Natl Acad Sci USA 98:1372813733

Lutz LB, Jamnongjit M, Yang W-H, Jahani D, Gill A, Hammes SR (2003) Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol Endocrinol 17:1106-1116

Ma H, Hong H, Huang SM, Irvine RA, Webb P, Kushner PJ, Coetzee GA, Stallcup MR (1999) Multiple signal input and output domains ofthe 160-kilodalton nuclear receptor coactivator proteins. Mol Cell Biol 19:6164-6173 MacLean HE, Choi WT, Rekaris G, Warne GL, Zajac JD (1995) Abnormal androgen receptor binding affinity in subjects with Kennedy's disease spinal and bulbar muscular atrophy. J Clin Endocrinol Metab 802:508-516 Mandrusiak LM, Beitel LK, Wang X, Scanlon TC, Chevalier-Larsen E, Merry DE, Trifiro MA (2003) Transglutaminase potentiates proteasome dysfunction induced by polyglutamine-expanded androgen receptor. Hum Mol Genet 12:1497-1506 Marcelli M, Ittmann M, Mariani S, Sutherland R, Nigam R, Murthy L, Zhao Y, DiConcini D, Puxeddu E, Esen A, Eastham J, Weigel NL, Lamb DJ (2000) Androgen receptor mutations in prostate cancer. Cancer Res 60:944-949 Marhefka, CA, Moore II, BM, Bishop, TC, Kirkovsky, L, Mukherjee, A, Dalton, JT, Miller, DD (2001) Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands. J Med Chem 44:1729-1740 Mariotti C, Castellotti B, Pareyson D, Testa D, Eoli M, Antozzi C, Silani V, Marconi R, Tezzon F, Siciliano G, Marchini C, Gellera C, Donato SD (2000) Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul Disord 106:391-397

Markus SM, Taneja SS, Logan SK, Li W, Ha S, Hittelman AB, Rogatsky I, Garabedian MJ (2002) Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus. Mol Biol Cell 13:670-682 Matias, PM, Carrondo, MA, Coelho, R, Thomaz, M, Zhao, X-Y, Wegg, A, Crusius, K, Egner, U, Donner, P (2002) Structural basis for the glucocorticoid response in a mutant human androgen receptor (ARccr) derived from an androgen-independent prostate cancer. J Med Chem 45:1439-1446

Matias, PM, Donner, P, Coelho, R, Thomaz, M, Peixoto, C, Macedo, S, Otto, N, Joschko, S, Scholz, P, Wegg, A, Basler, S, Schafer, M, Egner, U, Carrondo, MA (2000) Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J Biol Chem 275:26164-26171 McCampbell A, Taye AA, Whitty L, Penney E, Steffan JS, Fischbeck KH (2001) Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc Natl Acad Sci USA 98:15179-15184 McEwan IJ, Gustafsson J (1997) Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. Proc Natl Acad Sci USA 94:8485-8490 McKenna NJ, O'Malley BW (2002) Minireview: nuclear receptor coactivators-an update.

Endocrinology143:2461-2465 McManamny P, Chy HS, Finkelstein DI, Craythorn RG, Crack PJ, Kola I, Cheema SS, Horne MK, Wreford NG, O'Bryan MK, deKretser DM, Morrison JR (2002) A mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet 18: 2103-2111 McPhaul MJ, Griffin JE (1999). Male pseudohermaphroditism caused by mutations ofthe human androgen receptor. J Clin Endocrinol Metab 84:3435-3441 Merry DE, Kobayashi Y, Bailley CK, Taye AA, Fischbeck KH (1998) Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Hum Mol Genet 7: 693-701

Metzger E, Muller JM, Ferrari S, Buettner R, Schule R (2003) A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer. EMBO J 22:270280.

MeyerWJ 3rd, Migeon BR, Migeon CJ (1975). Locus on human X chromosome for dihydrotestos-

terone receptor and androgen insensitivity. Proc Natl Acad Sci USA 72: 1469-1472 Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, Rouleau G, Pinsky L (1993) Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nature Genet 5:184-188 Migeon BR, Brown TR, Axelman J, Migeon CJ (1981) Studies of the locus for androgen receptor: localization on the human X chromosome and evidence for homology with the Tfm locus in the mouse. Proc Natl Acad Sci USA 78:6339-6343 Migliaccio A, Castoria G, Di Domenico M, De Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F (2000) Steroid-induced androgen receptor-oestradiol receptor b-Src complex triggers prostate cancer cell proliferation. EMBO J 19:5406-5417

Miyamoto KK, McSherry SA, Dent GA, Sar M, Wilson EM, French FS, ShariefY, Mohler JL (1993) Immunohistochemistry of the androgen receptor in human benign and malignant prostate tissue. J Urol 149:1015-1019

Mizokami A, Chang C (1994) Induction of translation by the 5'-untranslated region of human androgen receptor mRNA. J Biol Chem 269:25655-25659 Mizokami A, Yeh SY, Chang C (1994) Identification of 3',5'-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter. Mol Endocrinol 8:77-88 Moilanen A-M, Poukka H, Karvonen U, Häkli M, Janne OA, Palvimo JJ (1998) Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Mol Cell Biol 18: 5128-5139 Mononen N, Syrjakoski K, Matikainen M, Tammela TL, Schleutker J, Kallioniemi OP, Trapman J, Koivisto PA (2000) Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene. Cancer Res 60:6479-6481 Montgomery BT, Young CY, Bilhartz DL, Andrews PE, Prescott JL, Thompson NF, Tindall DJ (1992) Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP. Prostate 21:63-73 Morishima Y, Murphy PJ, Li DP, Sanchez ER, Pratt WB (2000) Stepwise assembly of a glucocorticoid receptor.hsp90 heterocomplex resolves two sequential ATP-dependent events involving first hsp70 and then hsp90 in opening of the steroid binding pocket. J Biol Chem 275:1805418060

Morris MJ, Scher HI (2000) Novel strategies and therapeutics for the treatment of prostate carcinoma. Cancer 89:1329-1348 Moul JW, Srivastava S, McLeod DG (1995) Molecular implications of the antiandrogen withdrawal syndrome. Semin Urol 13:157-163 Müller JM, Isele U, Metzger E, Rempel A, Moser M, Pscherer A, Breyer T, Holubarsch C, Buettner R, Schule R (2000) FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J 19:359-369

Muller JM, Metzger E, Greschik H, Bosserhoff A-K, Mercep L, Buettner R, Schule R (2002) The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J 21:736-748 Murtha P, Tindall DJ, Young CY (1993) Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene. Biochemistry 32:6459-6464 Murtha PE, Zhu W, Zhang J, Zhang S, Young CY (1997) Effects of Ca++ mobilization on expression of androgen-regulated genes: interference with androgen receptor-mediated transactiva-tion by AP-I proteins. Prostate 33:264-270 Nazareth L, Weigel NL (1996) Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem 271:19900-19907 Nesterova M, Cho-Chung YS (2000) Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit. Antisense Nucleic Acid Drug Dev 10:423-433

Newmark JR, Hardy DO, Tonb DC, Carter BS, Epstein JI, Isaacs WB, Brown TR, Barrack ER (1992) Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci USA 89:6319-6323

Ning YM, Robins DM (1999) AML3/CBFalpha1 is required for androgen-specific activation of the enhancer of the mouse sex-limited protein (Slp) gene. J Biol Chem 274:30624-30630 Owen GI, Zelent A (2000) Origins and evolutionary diversification of the nuclear receptor super-

family. Cell Mol Life Sci 57:809-827 Palmberg C, Koivisto P, Kakkola L, Tammela TL, Kallioniemi OP, Visakorpi T (2000) Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer. J Urol 164:1992-1995 Palvimo JJ, Reinikainen P, Ikonen T, Kallio PJ, Moilanen A, Janne OA (1996) Mutual transcriptional interference between RelA and androgen receptor. J Biol Chem 271:24151-24156 Park JJ, Irvine RA, Buchanan G, Koh SS, Park JM, Tilley WD, Stallcup MR, Press MF, Coetzee GA (2000) Breast cancer susceptibility gene 1 (BRCA1) is a coactivator of the androgen receptor. Cancer Res 60:5946-5949 Persson H, Lievre CA-L, So der O, Villar MJ, Metsis M, Olson L, Ritzen M, Hokfelt T (1990) Expression of b-nerve growth factor receptor mRNA in sertoli cells downregulated by testosterone. Science 247:704-707 Peterziel H, Culig Z, Stober J, Hobisch A, Radmayr C, Bartsch G, Klocker H, Cato AC (1995) Mutant androgen receptors in prostatic tumors distinguish between amino-acid-sequence requirements for transactivation and ligand binding. Int J Cancer 63:544-550 Peterziel H, Mink S, Schonert A, Becker M, Klocker H, Cato ACB (1999) Rapid signalling by androgen receptor in prostate cancer cells. Oncogene 18:6322-6329 Poujol N, Wurtz J-M, Tahiri B, Lumbroso S, Nicolas J-C, Moras D, Sultan C (2000) Specific recognition of androgens by their nuclear receptor. A structure-function study. J Biol Chem 275:24022-24031

Poukka H, Aarnisalo P, Karvonen U, Palvimo JJ, Janne, OA (1999) Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J Biol Chem 274:1944119446

Poukka H, Aarnisalo P, Santti H, Janne OA, Palvimo JJ (2000a) Coregulator small nuclear RING finger protein (SNURF) enhances Sp1- and steroid-mediated transcription by different mechanisms. J Biol Chem 275:571-579 Poukka H, Karvonen U, Yoshikawa N, Tanaka H, Palvimo JJ, Janne OA (2000b) The RING finger protein SNURP modulates nuclear trafficking of the androgen receptor. J Cell Sci 113:29913001

Pratt WB, Toft DO (1997) Steroid receptor interactions with heat shock protein and immuno-

philin chaperones. Endocr Rev:18, 306-360 Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H (1999) Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulinlike growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines. Cancer Res 59:227-233 Quarmby VE, Yarbrough WG, Lubahn DB, French FS, Wilson EM (1990) Autologous down-

regulation of androgen receptor messenger ribonucleic acid. Mol Endocrinol 4:22-28 Quigley CA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM, French FS (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16:271-321

Rao J, Lee P, Benzeno S, Cardozo C, Albertus J, Robins DM, Caplan AJ (2001) Functional interaction of human Cdc37 with the androgen receptor but not with the glucocorticoid receptor. J Biol Chem 276:5814-5820 Reid J, Murray I, Watt K, Betney R, McEwan IJ (2002) The androgen receptor interacts with multiple regions of the large subunit of general transcription factor TFIIF. J Biol Chem 277:4124741253

Reinikainen P, Palvimo JJ, Janne OA (1996) Effects of mitogens on androgen receptor-mediated transactivation. Endocrinology 137:4351-4357 Rennie PS, Bruchovsky N, Leco KJ, Sheppard PC, McQueen SA, Cheng H, Snoek R, Hamel A, Bock ME, MacDonald BS, Nickel BE, Chang C, Liao S, Cattini PA, Matusik RJ (1993) Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol Endocrinol 7:23-36 Reutens AT, Fu M, Wang C, Albanese C, McPhaul MJ, Sun Z, Balk SP, Janne OA, Palvimo JJ, Pestell RG (2001) Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol Endocrinol 15:797-811 Riegman PH, Vlietstra RJ, van der Korput JA, Brinkmann AO, Trapman J (1991) The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol Endocrinol 5:1921-1930 Roche PJ, Hoare SA, Parker MG (1992) A consensus DNA-binding site for the androgen receptor.

Mol Endocrinol 6:2229-2235 Ruizeveldde Winter JA, Janssen PJ, Sleddens HM, Verleun Mooijman MC, Trapman J, Brinkmann AO, Santerse AB, Schroder FH, van der Kwast TH (1994). Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol 144:735-746 Rundlett SE, Miesfeld RL (1995) Quantitative differences in androgen and glucocorticoid receptor DNA binding properties contribute to receptor-selective transcriptional regulation. Mol Cell Endocrinol 109:1-10.

Sack JS, Kish KF, Wang C, Attar RM, Kiefer SE, An Y, Wu GY, Scheffler JE, Salvati ME, Krystek Jr SR, Weinmann R, Einspahr HM (2001) Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci USA 98:4904-4909 Sadar MD (1999) Androgen-independent induction of prostate-specific antigen expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways. J Biol Chem 274:7777-7783 Saitoh M, Takayanagi R, Goto K, FukamizuA, TomuraA, YanaseT, Nawata H (2002) The presence of both the amino- and carboxyl-terminal domains in the AR is essential for the completion of a transcriptionally active form with coactivators and intranuclear compartmentalization common to the steroid hormone receptors: a three-dimensional imaging study. Mol Endocrinol 16:694-706

Sato N, Sadar MD, Bruchovsky N, Saatcioglu F, Rennie PS, Sato S, Lange PH, Gleave ME (1997) Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP. J Biol Chem 272:17485-17494

Scher HI, Kolvenbag GJ (1997) The antiandrogen withdrawal syndrome in relapsed prostate cancer. Eur Urol 31:3-7; discussion 24-27 Schneikert J, Peterziel H, Defossez P-A, Klocker H, De Launoit Y, Cato ACB (1996) Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression. J Biol Chem 271:23907-23913 Schuurmans AL, Bolt J, Mulder E (1989) Androgen receptor-mediated growth and epidermal growth factor receptor induction in the human prostate cell line LNCaP. Urol Int 44:71-76 Schwabe J, Chapman L, Finch JT, Rhodes D (1993) The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 75:567-578 Segawa N, Nakamura M, Shan L, Utsunomiya H, Nakamura Y, Mori I, Katsuoka Y, Kakudo, K (2002) Expression and somatic mutation on androgen receptor gene in prostate cancer. Int J Urol 9:545-553

Sensibar JA, Sutkowski DM, Raffo A, Buttyan R, Griswold MD, Sylvester SR, Kozlowski JM, Lee C (1995) Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin). Cancer Res 55:2431-2437 Shabsigh A, Ghafar MA, de la Taille A, Burchardt M, Kaplan SA, Anastasiadis AG, Buttyan, R (2001) Biomarker analysis demonstrates a hypoxic environment in the castrated rat ventral prostate gland. J Cell Biochem 81:437-444 Shang Y, Myers M, Brown M (2002) Formation of the androgen receptor transcription complex. Mol Cell 9:601-610

Shao TC, Li H, Eid W, Ittmann M, Unni E, Cunningham GR (2003) In vivo preservation of steroid specificity in CWR22 xenografts having a mutated androgen receptor. Prostate 57:1-7

Sharma M, Zarnegar M, Li X, Lim B, Sun Z (2000) Androgen receptor interacts with a novel

MYST protein, HBO1. J Biol Chem 275:35200-35208 Shatkina L, Mink S, Rogatsch H, Klocker H, Langer G, Nestl A, Cato ACB (2003) The cochaperone Bag-1L enhances androgen receptor action via interaction with the NH2-terminal region of the receptor. Mol Cell Biol 20:7189-7197 Shenk JL, Fisher CJ, Chen S-Y, Zhou X-F, Tillman K, Shemshedini L (2001) p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction. J Biol Chem 276:38472-38479 Shimada N, Sobue G, Doyu M, Yamamoto K, Yasuda T, Mukai E, Kachi T, Mitsuma T (1995) X-linked recessive bulbospinal neuronopathy: clinical phenotypes and CAG repeat size in androgen receptor gene. Muscle Nerve 18:1378-1384 Simental JA, Sar M, Wilson EM (1992) Domain functions of the androgen receptor. J Steroid

Biochem Mol Biol 43:37-41 Simeoni S, Mancini MA, Stenoien DL, Marcelli M, Weigel NL, Zanisi M, Martini L, Poletti A (2000) Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract. Hum Mol Genet 9:133-44 Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538-541

Smith CL, Onate SA, Tsai MJ, O'Malley BW (1996) CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc Natl Acad Sci USA 93:8884-8888 Solit DB, Zheng FF, Drobnjak M, Munster PN, Higgins B, Verbel D, Heller G, Tong W, Cordon-CardoC, Agus DB,etal. (2002) 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts. Clin Cancer Res 8:986-993 Stanford JL, Damber JE, Fair WR, Sancho-Garnier H, Griffiths K, Gu F-L, Kiemeney LA (1999) Epidemiology of prostate Cancer. In Prostate Cancer - 2nd International Consultation on Prostate Cancer, Murphy GA, Khoury S, Partin AW, Denis L (eds) Paris, Health Publication Ltd. Paris pp 21-55

Steketee K, Berrevoets CA, Dubbink HJ, Doesburg P, Hersmus R, Brinkmann AO, Trapman J (2002) Amino acids 3-13 and amino acids in and flanking the 23FxxLF27 motif modulate the nteraction between the N-terminal and ligand-binding domain of the androgen receptor. Eur J Biochem 269:5780-5791 Stenoien DL, Cummings CJ, Adams HP, Mancini MG, Patel K, DeMartino GN, Marcelli M, Weigel NL, Mancini MA (1999) Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet 8:731-741 Suzuki H, Sato N, Watabe Y, Masai M, Seino S, Shimazaki J (1993) Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Mol Biol 46:759-765 Suzuki H, Akakura K, Komiya A, Aida S, Akimoto S, Shimazaki J (1996) Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome. Prostate 29:153-158 TakayamaS, Bimston DN, Matsuzawa S, Freeman BC, Aime-Sempe C, Xie Z, Morimoto RI. Reed JC (1997) BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J 16:4887-4896 Takayama S, KrajewskiS, Krajewska M, Kitada S, Zapata JM, Kochel K, Knee D, ScudieroD, Tudor G, Miller GJ, Miyashita T, Yamada M, Reed JC (1998) Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res 58:3116-3131 Takeyama K-I, Ito S, Yamamoto A, Tanimoto H, Furutani T, Kanuka H, Miura M, Tabata T, Kato S (2002) Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 35:855-864 Tan J, Sharief J, Hamil KG, Gregory CW, Zang D-Y, Sar M, French FS, Pretlow TG (1996) Altered ligand specificity of a mutant androgen receptor (AR) in the androgen dependent human prostate cancer cenograft, CWR-22: Comparison with the LNCaP mutant AR. J Urol 155:340A (Abstract)

Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, Balk SP (1995) Mutation of the androgen-receptor gene in metastatic an drogen-in dependent prostate cancer. N Engl J Med 332, 1393-1398. Taplin ME, Rajeshkumar B, Halabi S, Werner CP, Woda BA, Picus J, Stadler W, Hayes DF, Kantoff PW, Vogelzang NJ, Small EJ (2003) Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663. J Clin Oncol 21:2673-2678

Thigpen AE, Davis DL, Milatovich A, Mendonca BB, Imperato-McGinley J, Griffin JE, Francke U, Wilson JD, Russell DW (1992) Molecular genetics of steroid 5alpha-reductase 2 deficiency. J Clin Invest 90:799-809 Thompson J, Saatcioglu F, Janne OA, Palvimo JJ (2001) Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. Mol Endocrinol 15:923-935

Thornton JW, Kelley DB (1998) Evolution of the androgen receptor: structure-function implications. Bioessays 20:860-869 Tilley WD, Marcelli M, Wilson JD, McPhaul, MJ (1989) Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci USA 86:327-331 Tilley WD, Marcelli M, McPhaul MJ (1990a) Expression of the human androgen receptor gene utilizes a common promoter in diverse human tissues and cell lines. J Biol Chem 265:1377613781

Tilley WD, Wilson CM, Marcelli M, McPhaul, M. J. (1990b) Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res 50:5382-5386. Tilley WD, Buchanan G, Hickey TE, Bentel JM (1996) Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Clin Cancer Res 2:277-285

Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK Rosenfeld MG (1997) The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387:677-684

Trapman J, Klaassen P, Kuiper GG, van der Korput JA, Faber PW, van Rooij HC, Geurts van Kessel A, Voorhorst MM, Mulder E, Brinkmann AO (1988) Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun 153:241-248 Truica CI, Byers S, Gelmann EP (2000) Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res 60:4709-4713 Trump D, Wilding G, Small EJ, Soulie P, Gupta A (2002) A pilot trial of ZD1839 (Iressa), an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), in combination with docetaxel and estramustine in patients with hormone-refractory prostate cancer (HRPC). J Urol 167, Abstract at the Annual Congress of the American Urological Association

Tsai MJ, O'Malley BW (1994) Molecular mechanisms of action of steroid/thyroid receptor super-

family members. Annu Rev Biochem 63:451-486 Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, Yong EL (1997) Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 82:3777-3782 van der Kwast T, Schalken J, Ruizeveld de Winter J, van Vroonhoven C, Mulder E, Boersma W, Trapman J (1991) Androgen receptors in endocrine therapy-resistant human prostate cancer. Int J Cancer 48:189-193 Veldscholte J, Ris Stalpers C, Kuiper GG, Jenster G, Berrevoets C, Claassen E, Van Rooij HC, Trapman J, Brinkmann AO, Mulder E (1990a) A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 173:534-540

Veldscholte J, Voorhorst OM, Bolt DVJ, Van RH, Trapman J, Mulder E (1990b) Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids. Biochim Biophys Acta 1052:187-194 Veldscholte J, Berrevoets CA, Ris Stalpers C, Kuiper GG, Jenster G, Trapman J, Brinkmann AO, Mulder E (1992a) The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J Steroid Biochem Mol Biol 41:665-669 Veltscholte J, Berrevoets CA, Zegers ND, van der Kvast TH, Grootegoed JA, Mulder E (1992b) Hormone-induced dissociation of the androgen receptor-heat-shock protein complex. Use of a new monoclonal antibody to distinguish transformed from nontransformed receptors. Biochemistry 31:7422-7430 VerrijdtG, HaelensA, Claessens F (2003) Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression. Mol Genet Metab 78:175-185 Verrijdt G, Schoenmakers E, Alen P, Haelens A, Peeters B, Rombauts W, Claessens F (1999) Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element. Mol Endocrinol 13:1558-1570 Verrijdt G, Schauwaers K, Haelens A, Rombauts W, Claessens F (2002) Functional interplay between two response elements with distinct binding characteristics dictates androgen specificity of the mouse sex-limited protein enhancer. J Biol Chem 277:35191-35201 Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi O-P (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9:401-406 Wang C, Young WJ, Chang C (2000) Isolation and characterization of the androgen receptor mutants with divergent transcriptional activity in response to hydroxyflutamide. Endocrine 12:69-76

WangQ, SharmaD, RenY, Fon dell JD (2002) A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression. J Biol Chem 277:42852-42858 Wellington CL

Hair Loss Prevention

Hair Loss Prevention

The best start to preventing hair loss is understanding the basics of hair what it is, how it grows, what system malfunctions can cause it to stop growing. And this ebook will cover the bases for you. Note that the contents here are not presented from a medical practitioner, and that any and all dietary and medical planning should be made under the guidance of your own medical and health practitioners. This content only presents overviews of hair loss prevention research for educational purposes and does not replace medical advice from a professional physician.

Get My Free Ebook

Post a comment